Program synergy between Institutions
Collaborative Workforce Education Initiatives
Memorial Sloan-Kettering Cancer Center and Hunter College maintain numerous active academic and scientific collaborations that benefit students at the undergraduate and graduate levels, as well as faculty members. Both institutions seek to deepen and strengthen these collaborations, a goal that is best supported through physical proximity.
Medical Technologist Licensing
New York City faces a severe shortage of licensed medical technologists, and medical centers recognize that partnering with educators is the best way to train a professional workforce. Hunter College and Memorial Sloan-Kettering seek to form a mutually beneficial collaboration that will provide clinical internship sites at Memorial Sloan-Kettering for Hunter students and provide continuing education for Memorial Sloan-Kettering employees.
Hunter College and Memorial Sloan-Kettering are exploring new programs in laboratory science that would be enhanced through the 74th Street co-location, including the joint development of a program in cytotechnology.
Cytotechnology is the microscopic study of cells to detect disease or infection, and the program leads to New York State licensure. Memorial Sloan-Kettering employees could enroll in one of Hunter's medical laboratory science degree or certificate programs, and qualified Hunter students would have new pathways to placement and employment opportunities at Memorial Sloan-Kettering.
A highly trained nursing staff is a prerequisite to delivering excellent patient care in today's complex clinical environment, and this is particularly true in oncology. Nursing executives at Memorial Sloan-Kettering and Hunter's School of Nursing are exploring programs that will benefit Memorial Sloan-Kettering's nursing staff and Hunter students. For example, many Memorial Sloan-Kettering nurses are currently enrolled in Hunter's master's degree programs, and Hunter nursing students are placed at Memorial Sloan-Kettering for clinical learning and clinical practicum.
This new site will facilitate increased clinical placements for Hunter students, development of post-baccalaureate programs for specialty nursing positions (chemotherapy and operating room), joint research efforts, and advanced education for Memorial Sloan-Kettering nurses.
Collaborative Scientific Research Initiatives
Memorial Sloan-Kettering Cancer Center and Hunter College maintain numerous active academic and scientific collaborations that expand the intellectual productivity and potential for scientific breakthroughs at the undergraduate, graduate, and faculty levels. Both institutions seek to deepen and strengthen these collaborations, a goal that is best supported through physical proximity.
Hunter College and Memorial Sloan-Kettering faculty have a long and robust history of collaborative scientific investigation, particularly in the biological sciences. Our faculty and researchers work together on major investigatory and curricular programs that create educational and advancement opportunities for Hunter students and Memorial Sloan-Kettering staff.
The newest collaboration is a flagship program in chemistry funded by the National Science Foundation. The Integrative Graduate Education and Research Traineeship (IGERT) will support 15 PhD candidates in radiochemistry.
The goal of the IGERT is to engage in cutting-edge research in cancer diagnosis and therapy using radioactive materials. To achieve this goal, PhD graduate students work with faculty mentors at Hunter and faculty at Memorial Sloan-Kettering. Another important goal is the education and training of these PhD students in understanding and implementation of radioactive materials for diagnosis and therapy of cancer.
Led by Weill Cornell Medical College, Hunter College, and Memorial Sloan-Kettering, the Clinical Translational Science Center (CTSC) is a model consortium of East Side institutions that seeks to break down institutional and disciplinary silos to accelerate clinical and community applications of basic scientific discoveries. The first Clinical Translational Science Award supported the establishment of this multi-institutional consortium in 2007, and most recently, the CTSC has received a five-year renewal grant of almost $50 million.
The new complex will build on this foundation and support significant efforts in clinical research planned by Memorial Sloan-Kettering. It will bring Hunter faculty together with Memorial Sloan-Kettering researchers focused on evaluating the effectiveness of new therapies in early-stage clinical trials.